Form 4: ClearPoint Neuro CEO Reports Stock Transaction
Insider Transaction (Form 4)
Joseph Burnett, CEO and President and a Director of ClearPoint Neuro, Inc., reported multiple transactions in common stock on September 2, 2026.
Summary
- Option exercise/conversion: acquired 12,517 Common Stock at $3.47 ($43,434) on September 2, 2026; holds 130,720 after (Direct).
- Option exercise/conversion: disposed of 12,517 Stock Options (right to buy) on September 2, 2026; holds 61,887 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Joseph Burnett — Director, Officer (CEO and President)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-02 | Option exercise/conversion | Common Stock | 12,517 | $3 | $43.4K | 130,720 |
| 2026-09-02 | Option exercise/conversion | Stock Options (right to buy) | 12,517 | — | — | 61,887 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-02 | Option exercise/conversion (12,517 shares) |
| 2026-09-02 | Option exercise/conversion (12,517 shares) |
Keywords
insider transaction, Form 4, CLPT, ClearPoint Neuro, Inc., neutral, Joseph Burnett
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.